Home ••• Newswires by Industry • Countries • U.S. States • World Media Directory

Pharmaceutical Industry News ••• Topics • Countries • U.S. States

Ustekinumab News Monitoring

Get by Email • RSS

Published on May 8, 2025

Certain Psoriasis Patients at Higher Risk of Excessive Sun Exposure: Study

Researchers have found in a new research that female, younger, average-weight psoriasis patients with intermediate skin phototype and a history of phototherapy are more prone to excessive sun exposure, often linked to tanning behaviors.The findings …

Source: Medical Dialogues - Indeterminate
Published on May 7, 2025

FDA Grants Ustekinumab-Aekn Interchangeability Designation for Stelara

The FDA approved ustekinumab-aekn (Selarsdi) as an interchangeable biosimilar with ustekinumab (Stelara). The product is currently available and interchangeable for all indications of ustekinumab, including treatment of psoriatic arthritis, plaque …

Source: Drug Topics - Neutral
Published on May 7, 2025

Potential U.S. Tariffs on Pharmaceuticals Expected to Have Minimal Impact on Alvotech’s Product Revenues in 2025

REYKJAVIK, Iceland, May 07, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO) (the “Company”) a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today issued a statement on the …

Distribution channels: Technology ...
Published on May 7, 2025

EULAR Task Force Expands Pregnancy-Safe Drug Options

All tumor necrosis factor (TNF) inhibitors are safe to use throughout pregnancy, according to new recommendations from the European Alliance of Associations for Rheumatology (EULAR). All biologic disease-modifying antirheumatic drugs (bDMARDs) can also be …

Source: Medscape - Neutral
Published on May 6, 2025

Teva and Alvotech Gain FDA Interchangeability for SELARSDI Biosimilar to Stelara

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd., and Alvotech announced that the U.S. Food and Drug Administration (FDA) has approved SELARSDI™ (ustekinumab-aekn) injection as interchangeable with the reference biologic …

Source: Pharma Journalist - Neutral
Published on May 6, 2025

Study Highlights Cardiovascular Safety of Systemic Therapies for Psoriasis

New findings point to a possible link between apremilast and interleukin (IL)-17 with a lower incidence of major adverse cardiovascular events (MACE) in patients with psoriasis, whereas cyclosporine showed a higher incidence versus methotrexate.1 Juan José …

Source: HCPLive - Pending
Published on May 5, 2025

Ustekinumab-aekn Now Interchangeable With Reference for PsA, PsO, CD, UC

Ustekinumab-aekn (Selarsdi) has received the interchangeable designation with the reference biologic ustekinumab (Stelara), as of April 30, 2025, for treating adults and pediatric with psoriatic arthritis, plaque psoriasis, Crohn disease, and ulcerative …

Source: HCPLive - Pending
Published on May 6, 2025

FDA approves Selarsdi injection as interchangeable with Stelara

Teva Pharmaceuticals and Alvotech have announced that the US Food and Drug Administration (FDA) has approved the Selarsdi (ustekinumab-aekn) injection as interchangeable with reference biologic Stelara (ustekinumab). As of 30 April, Selarsdi is now …

Source: Pharmaceutical Technology - Neutral
Published on May 5, 2025

Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (...

The U.S. FDA has approved SELARSDI™ (ustekinumab-aekn) as interchangeable with the reference biologic Stelara® (ustekinumab) in all presentations matching the reference product, effective as of April 30, 2025 SELARSDI is approved for all indications …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on May 5, 2025

Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (...

The U.S. FDA has approved SELARSDI™ (ustekinumab-aekn) as interchangeable with the reference biologic Stelara® (ustekinumab) in all presentations matching the reference product, effective as of April 30, 2025 SELARSDI is approved for all indications …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
Published on May 5, 2025

Why Is Israel-Based Generic Drug Focused Teva Pharmaceutical Stock Trading Higher On Monday?

The U.S. Food and Drug Administration (FDA) has approved Teva Pharmaceutical Industries Ltd. TEVA and Alvotech’s ALVO Selarsdi (ustekinumab-aekn) injection as interchangeable with the reference biologic Johnson & Johnson’s JNJ Stelara (ustekinumab). As …

Source: Benzinga - Neutral
Published on May 5, 2025

Biocon Biologics bags multiple market access for its biosimilar drug Yesintek

Biocon Biologics’ Yesintek has already been approved by major Pharmacy Benefit Managers (PBMs) & Insurers in the US | Photo Credit: DHIRAJ SINGH Biocon Biologics, a biosimilars company and subsidiary of Biocon Ltd, secured multiple market access …

Source: The Hindu Business Line - Neutral
Published on May 4, 2025

Johnson and Johnson Gets CDSCO Panel nod for Additional Indication of Ustekinumab solution for injection

New Delhi: The Subject Expert Committee (SEC), functional under the Central Drug Standard Control Organization (CDSCO), has granted approval to Johnson and Johnson for the proposed additional indication of Ustekinumab solution for injection 45 mg and 90 mg …

Source: Medical Dialogues - Indeterminate
Published on May 7, 2025

This Week’s Biopharma News: EU Launches Initiative to Attract Scientists from US

Andrew Hecht, CC BY 2.0 <https://creativecommons.org/licenses/by/2.0>, via Wikimedia Commons EU invests to invite science In response to US research funding cuts, the European Union has launched a €500 million ($566 million) …

Source: The Medicine Maker - Neutral
Published on May 6, 2025

Stelara Biosimilar Yesintek Gains Coverage on Leading Formularies

Biocon Biologics’s Yesintek (ustekinumab-kfce) has secured access on several major plans and formularies that cover in total more than 100 million lives. Plan/PBM coverage includes: Express Scripts has added Yesintek to the National Preferred Formulary …

Source: Formulary Watch - Pending
Published on Sep 16, 2024

Human medicines European public assessment report (EPAR): Tremfya, guselkumab, Date of authorisation: 10/11/2017, ...

Plaque psoriasis Three main studies involving 2,700 adults found Tremfya effective for treating moderate to severe plaque psoriasis in patients for whom treatments applied to the skin did not work well enough. A main measure of effectiveness was a …

Source: European Medicines Agency - Pending
Published on May 6, 2025

How the U.S. Compares to Europe on Biosimilar Approvals and Products In the Pipeline – Updated May 2, 2025

FDA approves Omylco® (omalizumab), first biosimilar of Xolair®. After Q1, FDA and EMA on track for a record number of biosimilar authorizations in 2025. Biosimilars, once a niche segment in the pharmaceutical industry, are now making a significant impact …

Source: JD Supra - California - Neutral
Published on May 6, 2025

Biocon Biologics secures market access coverage for Stelara biosimilar

Shreehas Tambe, CEO and managing director, Biocon Biologics, said, “Yesintek (Ustekinumab-kfce) represents an important milestone for Biocon Biologics, as this is the first product we have launched in the United States as a fully integrated biosimilars …

Source: Drug Store News - Pending
Published on May 6, 2025

One Young Woman’s Journey with Rheumatoid Arthritis

(BPT) - Content sponsored and provided by Pfizer. Olivia partnered with Pfizer to share her experience living with moderate to severe rheumatoid arthritis (RA). Olivia, a native of Soldotna, Alaska, is pursuing a master's degree in clinical psychology …

Source: The Call & Times - Rhode Island - Neutral

03 days 23:41:43

Featured Releases

Got News to Share? · Submit · See All

Published on May 8, 2025 - 21:52 GMT

Meeting of the Oncologic Drugs Advisory Committee - 05/20/2025

Date: May 20 - 21, 2025 Day1: Tue, May 20 8:00 a.m. - 05:00 p.m. ET Day2: Wed, May 21 8:00 a.m. - 05:00 p.m. ET What is an advisory committee? Advisory committees provide independent expert advice to the FDA on broad scientific topics or on certain …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on May 8, 2025 - 21:00 GMT

Apimeds Pharmaceuticals US, Inc. Announces Pricing of Initial Public Offering

Hopewell, New Jersey, May 08, 2025 (GLOBE NEWSWIRE) -- Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) (“Apimeds” or the “Company”), a clinical stage biopharmaceutical company that is in the process of developing Apitox, an intradermally …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on May 8, 2025 - 20:17 GMT

Fennec Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025

RESEARCH TRIANGLE PARK, N.C., May 08, 2025 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the Company will release its first quarter 2025 financial results …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 8, 2025 - 20:05 GMT

Terns Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Corporate Updates

Initiated dose expansion in Phase 1 CARDINAL trial of TERN-701 in 2L+ CML Additional safety and efficacy data including 6-month MMR expected in 4Q25 Phase 2 FALCON trial of TERN-601 for obesity is enrolling well with top-line 12-week weight loss data …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on May 8, 2025 - 20:05 GMT

Crinetics Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

Regulatory Interactions and Commercial, Medical, and Corporate Preparations On-Track for Paltusotine New Drug Application with September 25, 2025 PDUFA Date CALM-CAH Phase 3 Study of Atumelnant for the Treatment of Adults with Congenital Adrenal …

Distribution channels:
Published on May 8, 2025 - 20:01 GMT

Shuttle Pharma FDA Orphan-Drug Nears Patient Enrollment Milestone for Phase 2 Clinical Trial

GAITHERSBURG, Md., May 08, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 8, 2025 - 20:02 GMT

Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2025 Financial Results

Soquelitinib data from cohorts 1-3 of atopic dermatitis Phase 1 clinical trial demonstrate favorable safety and efficacy profile, including earlier and deeper responses in cohort 3 compared to cohorts 1-2 Phase 3 registrational clinical trial of …

Distribution channels:
Published on May 8, 2025 - 20:01 GMT

Corvus Pharmaceuticals Announces Data from Cohorts 1-3 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for ...

Data continue to demonstrate favorable safety and efficacy profile, including earlier and deeper responses in cohort 3 compared to cohorts 1-2 Data to be presented in an oral session and poster at the Society for Investigative Dermatology 2025 Annual …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Got news to share? Submit it now.

Load more pharmaceuticals news or search news using your own keywords. There are 810,957,655 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Pharmaceutical Industry News by Country

Pharmaceutical Industry News by U.S. State

Pharmaceutical Industry News Topics

Online News Publications

World News Report

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter

Create RSS Feed

NewsPlugin for WordPress

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire

Events

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 04/18/2025

World Media Directory

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Published on May 9, 2025 - 04:09 GMT

Tele911 Launches Fastest Path to Emergency Care in the U.S.

From Login to Live Board-Certified Emergency Room Physician in Under 40 Seconds PASADENA, CA, UNITED STATES, May 9, 2025 /⁨EINPresswire.com⁩/ -- In a bold step toward redefining emergency medical access, Tele911 today announced the launch of its …

Distribution channels: Emergency Services, Healthcare & Pharmaceuticals Industry ...
Published on May 9, 2025 - 04:03 GMT

Global Automated Cannabis Testing Market Set for Robust Growth, Projected to Achieve 11-13% CAGR from 2022 to 2032 | FMI

Automated Cannabis Testing Market Analysis – Growth & Trends 2022-2032 NEWARK, DE, UNITED STATES, May 9, 2025 /⁨EINPresswire.com⁩/ -- The global automated cannabis testing market is poised for significant expansion, with industry experts …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 9, 2025 - 04:03 GMT

Global Organ Transport Devices Market Poised for Growth to Reach USD 735.8 Million by 2035 at a CAGR of 4.9% | FMI

The Organ Transport Devices Market is segmented by devices, disposables, perfusion solutions, and region from 2025 to 2035 NEWARK, DE, UNITED STATES, May 9, 2025 /⁨EINPresswire.com⁩/ -- The global market for organ transport devices is witnessing …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 9, 2025 - 00:00 GMT

Renowned Neurosurgeon Dr. Mohana Rao (Dr. Rao) Chooses Guntur Over Global Metropolises, Revolutionizing Local Healthcare

Dr. Mohana Rao Patibandla's Quiet Revolution in Neurosurgery GUNTUR, ANDHRA PRADESH, INDIA, May 9, 2025 /⁨EINPresswire.com⁩/ -- Renowned Neurosurgeon Dr. Rao Chooses Guntur Over Global Metropolises, Revolutionizing Local Healthcare Dr. …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
Published on May 8, 2025 - 23:32 GMT

Guardian Recovery Announces the Opening of Southern Maine Recovery Center in Westbrook, ME

Guardian Recovery, a leading provider of substance use disorder and mental health treatment announces the grand opening of Southern Maine Recovery Center. WESTBROOK, ME, UNITED STATES, May 8, 2025 /⁨EINPresswire.com⁩/ -- Guardian Recovery, a …

Distribution channels: Companies, Culture, Society & Lifestyle ...
Published on May 8, 2025 - 23:06 GMT

Guardian Recovery Welcomes Ross Bacon as Vice President of Business Development

Guardian Recovery announces the appointment of Ross Bacon as Vice President of Business Development bringing valuable expertise to support continued growth. DELRAY BEACH, FL, UNITED STATES, May 8, 2025 /⁨EINPresswire.com⁩/ -- Guardian Recovery …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on May 8, 2025 - 23:05 GMT

Guardian Recovery Announces Rebranding of Immersion Facilities in South Florida

Guardian Recovery announces the rebranding of two key treatment facilities in South Florida to further unify its expansive network of treatment facilities. DELRAY BEACH, FL, UNITED STATES, May 8, 2025 /⁨EINPresswire.com⁩/ -- Guardian Recovery …

Distribution channels: Companies, Culture, Society & Lifestyle ...
Published on May 8, 2025 - 22:27 GMT

Stem Health Plus Specializes in Care for Chronic Skin Conditions

Stem Health Plus Offers Specialized Care for Chronic Skin Conditions WONDER LAKE, IL, UNITED STATES, May 8, 2025 /⁨EINPresswire.com⁩/ -- Stem Health Plus proudly announces its expanded focus on treating chronic skin conditions through advanced …

Distribution channels: Emergency Services, Healthcare & Pharmaceuticals Industry ...
Published on May 8, 2025 - 22:24 GMT

Clean Remedies Announces Memorial Day Sale Honoring Veterans, Military, and Frontline Workers

Clean Remedies is proud to announce its upcoming Memorial Day Sale of 25% off sitewide, taking place from May 23 to May 26, 2025. AVON, OH, UNITED STATES, May 8, 2025 /⁨EINPresswire.com⁩/ -- Clean Remedies, a wellness company known for its plant- …

Distribution channels: Conferences & Trade Fairs, Consumer Goods ...
Published on May 8, 2025 - 22:21 GMT

Guardian Recovery's Chief Clinical Officer Featured on Huberman Lab Podcast

Ryan Soave, Chief Clinical Officer at Guardian Recovery, recently appeared as a guest expert on the influential Huberman Lab podcast. DELRAY BEACH, FL, UNITED STATES, May 8, 2025 /⁨EINPresswire.com⁩/ -- Ryan Soave, Chief Clinical Officer at …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on May 8, 2025 - 21:59 GMT

Guardian Recovery's New Pathway Counseling Centers Now In-Network With AmeriHealth

Guardian Recovery announces that their New Pathway Counseling Centers are now in-network with AmeriHealth insurance, expanding access to treatment services. PINE BROOK, NJ, UNITED STATES, May 8, 2025 /⁨EINPresswire.com⁩/ -- Guardian Recovery …

Distribution channels: Companies, Culture, Society & Lifestyle ...
Published on May 8, 2025 - 21:50 GMT

Guardian Recovery - Montville Adolescent Center Now In-Network With AmeriHealth

Guardian Recovery announces that its Montville Adolescent Center is now in-network with AmeriHealth insurance, expanding access for adolescents. MONTVILLE, NJ, UNITED STATES, May 8, 2025 /⁨EINPresswire.com⁩/ -- Guardian Recovery announces that its …

Distribution channels: Companies, Culture, Society & Lifestyle ...
Published on May 8, 2025 - 21:47 GMT

Comparing In-Office Teeth Whitening with Over-the-Counter Kits: What Sets Them Apart

SLIDELL, LA, UNITED STATES, May 8, 2025 /⁨EINPresswire.com⁩/ -- Teeth whitening remains one of the most requested cosmetic dental treatments in the United States. While over-the-counter whitening kits are widely available and often marketed as …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on May 8, 2025 - 21:11 GMT

Earth Buddy Offers CBD Products to Keep Pets Calm This Fourth of July

Earth Buddy is shining a light on the growing need for accessible education around using CBD for pets, especially when calming stressed-out pets. LONGMONT, CO, UNITED STATES, May 8, 2025 /⁨EINPresswire.com⁩/ -- Earth Buddy, a well-established pet …

Distribution channels: Consumer Goods, Culture, Society & Lifestyle ...
Published on May 8, 2025 - 21:08 GMT

Guardian Recovery - Dallas Addiction Center Now In-Network with Magellan Health Insurance

Guardian Recovery's Dallas Addiction Center announces In-network Status With Magellan Health insurance, significantly enhancing treatment accessibility. DALLAS, TX, UNITED STATES, May 8, 2025 /⁨EINPresswire.com⁩/ -- Guardian Recovery's …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on May 8, 2025 - 20:50 GMT

WellMedica Pioneers Sexual Wellness Treatments for Men and Women

WellMedica offers non-surgical treatments that support men's and women’s sexual wellness, addressing erectile dysfunction and hormonal changes. RESTON, VA, UNITED STATES, May 8, 2025 /⁨EINPresswire.com⁩/ -- In recent years, sexual wellness has …

Distribution channels: Beauty & Hair Care, Culture, Society & Lifestyle ...
Published on May 8, 2025 - 20:35 GMT

Pro Football Hall of Famer Terrell Davis Inspires Colorado Students and Promotes Schoolwide Mental Health Screening

DENVER, CO, UNITED STATES, May 8, 2025 /⁨EINPresswire.com⁩/ -- On April 30, Super Bowl MVP and Pro Football Hall of Famer Terrell Davis visited Colorado’s Conifer High School to connect with students and launch the Rising Together Schoolwide Mental …

Distribution channels: Culture, Society & Lifestyle, Education ...
Published on May 8, 2025 - 20:17 GMT

Nurses Week 2025 in Full Swing: Team Select Home Care Kicks Off the Celebration with Gifts, Giveaways, and Gratitude

Team Select Home Care celebrates Nurses Week 2025 with giveaways, gifts, and gratitude for in-home nurses making a difference every day. PHOENIX, AZ, UNITED STATES, May 8, 2025 /⁨EINPresswire.com⁩/ -- Nurses Week 2025 is in full force, and …

Distribution channels: Business & Economy, Education ...
Published on May 8, 2025 - 20:05 GMT

Nutritionist Linda Lin Hosts 'Food Is Medicine' — A Wellness Experience Blending Science, Nutrition & Sound Healing

A hands-on evening of education and healing, featuring a nutrition talk, wellness insights, and an immersive sound bath—led by holistic nutritionist Linda Lin. SANTA MONICA, CA, UNITED STATES, May 8, 2025 /⁨EINPresswire.com⁩/ -- Certified …

Distribution channels: Beauty & Hair Care, Culture, Society & Lifestyle ...
Published on May 8, 2025 - 20:00 GMT

Xoted Biotechnology Labs Holds Soft Launch at Spartanburg Community College’s Spark Center

Company’s ecosystem includes manufacturing and R&D facilities in South Carolina, Nevada and Tennessee NEW YORK, NY, UNITED STATES, May 8, 2025 /⁨EINPresswire.com⁩/ -- DRC Ventures, a global leader in biotech, nutraceutical, and environmental …

Distribution channels: Business & Economy, Companies ...